PTPRN2
Basic information
Region (hg38): 7:157539056-158587823
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 16 | 28 | |||
missense | 55 | 10 | 73 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 0 | |||||
Total | 0 | 0 | 55 | 20 | 27 |
Variants in PTPRN2
This is a list of pathogenic ClinVar variants found in the PTPRN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-157540717-C-A | Benign (Oct 01, 2023) | |||
7-157540784-T-C | not specified | Uncertain significance (Aug 10, 2021) | ||
7-157548964-G-A | Benign (Dec 31, 2019) | |||
7-157548964-G-C | Likely benign (Oct 19, 2018) | |||
7-157568929-C-G | not specified | Uncertain significance (Apr 06, 2024) | ||
7-157571467-C-T | not specified | Uncertain significance (May 31, 2023) | ||
7-157571487-T-C | Likely benign (Jun 05, 2018) | |||
7-157576606-G-A | Benign (Dec 31, 2019) | |||
7-157576675-G-C | not specified | Uncertain significance (Apr 16, 2024) | ||
7-157576706-G-A | not specified | Uncertain significance (Apr 12, 2022) | ||
7-157578025-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
7-157578031-T-C | not specified | Uncertain significance (Mar 18, 2024) | ||
7-157578083-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
7-157595247-G-T | not specified | Uncertain significance (Jul 11, 2023) | ||
7-157595289-C-T | Likely benign (Jun 05, 2018) | |||
7-157595301-C-T | Benign (Jun 01, 2018) | |||
7-157595307-G-A | Likely benign (Oct 10, 2018) | |||
7-157621363-G-A | Likely benign (Dec 31, 2019) | |||
7-157621367-A-G | Malignant tumor of prostate | Uncertain significance (-) | ||
7-157621372-G-GGCCAGTTTCCACCGCCCGTAACCCAGGCTTCCTGCCCCCGGGGCTGGTACGTACAGGTCAGCACA | Benign (Dec 31, 2019) | |||
7-157621435-C-T | Benign (Jun 01, 2018) | |||
7-157621454-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
7-157621456-T-C | Benign (Nov 06, 2018) | |||
7-157621475-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
7-157656369-G-T | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPRN2 | protein_coding | protein_coding | ENST00000389418 | 23 | 1048731 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.39e-7 | 1.00 | 125706 | 1 | 41 | 125748 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0573 | 630 | 634 | 0.994 | 0.0000423 | 6455 |
Missense in Polyphen | 182 | 233.28 | 0.78018 | 2470 | ||
Synonymous | 0.242 | 292 | 297 | 0.982 | 0.0000229 | 2106 |
Loss of Function | 4.04 | 20 | 51.1 | 0.391 | 0.00000258 | 569 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000416 | 0.000414 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000165 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000172 | 0.000167 |
Middle Eastern | 0.000165 | 0.000163 |
South Asian | 0.000267 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in vesicle-mediated secretory processes. Required for normal accumulation of secretory vesicles in hippocampus, pituitary and pancreatic islets. Required for the accumulation of normal levels of insulin-containing vesicles and preventing their degradation. Plays a role in insulin secretion in response to glucose stimuli. Required for normal accumulation of the neurotransmitters norepinephrine, dopamine and serotonin in the brain. In females, but not in males, required for normal accumulation and secretion of pituitary hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (By similarity). Required to maintain normal levels of renin expression and renin release (By similarity). May regulate catalytic active protein-tyrosine phosphatases such as PTPRA through dimerization (By similarity). Has phosphatidylinositol phosphatase activity; the PIPase activity is involved in its ability to regulate insulin secretion. Can dephosphorylate phosphatidylinositol 4,5-biphosphate (PI(4,5)P2), phosphatidylinositol 5-phosphate and phosphatidylinositol 3- phosphate (By similarity). Regulates PI(4,5)P2 level in the plasma membrane and localization of cofilin at the plasma membrane and thus is indirectly involved in regulation of actin dynamics related to cell migration and metastasis; upon hydrolyzation of PI(4,5)P2 cofilin is released from the plasma membrane and acts in the cytoplasm in severing F-actin filaments (PubMed:26620550). {ECO:0000250|UniProtKB:P80560, ECO:0000250|UniProtKB:Q63475, ECO:0000269|PubMed:26620550}.;
- Disease
- DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8637868, ECO:0000269|PubMed:8798755, ECO:0000269|PubMed:8878534}.;
- Pathway
- Type I diabetes mellitus - Homo sapiens (human);Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0998
Intolerance Scores
- loftool
- 0.730
- rvis_EVS
- 0.89
- rvis_percentile_EVS
- 89.2
Haploinsufficiency Scores
- pHI
- 0.188
- hipred
- N
- hipred_score
- 0.361
- ghis
- 0.466
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.780
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ptprn2
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- protein dephosphorylation;lipid metabolic process;neurotransmitter secretion;negative regulation of GTPase activity;peptidyl-tyrosine dephosphorylation;insulin secretion involved in cellular response to glucose stimulus;neutrophil degranulation
- Cellular component
- endoplasmic reticulum lumen;plasma membrane;integral component of plasma membrane;cell junction;integral component of synaptic vesicle membrane;secretory granule membrane;synaptic vesicle membrane;terminal bouton;receptor complex;ficolin-1-rich granule membrane
- Molecular function
- transmembrane receptor protein tyrosine phosphatase activity